ACELLYTRON
Wuxi Biologics (Shanghai) Co., Ltd.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79392046 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Timeline
| 2023-11-28 | Application Filed |
| 2024-03-21 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2024-03-21 | Status: Live/Pending |
| 2024-03-23 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Wuxi Biologics (Shanghai) Co., Ltd. |
| Address | Building 2, No. 31 Yiwei Road, CN |
| Legal Entity Type | Corporation |
| Legal Entity State | CN |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| International Codes: | 35 |
| U.S. Codes: | 100,101,102 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Chemico-pharmaceutical preparations; biochemical medicines; vaccine preparations; influenza vaccine; chemotherapeutics; stem cells for medical purposes; medicines for human purposes; drugs for medical purposes; pharmaceutical preparations; drugs for cancer; medical preparation for treating diseases and disorders related to the immune system; biological agent for treating cancer; pharmaceutical products for the prevention and treatment of cancer; living cells for medical use; medical cell inhibitor; reagents for medical purposes; anticancer agent; diagnostic reagents for medical purposes; tumor suppressor; medical cells; dietetic substances adapted for medical use; biological preparations for veterinary purposes |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2024-03-21 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2024-03-23 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2024-03-27 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2024-06-26 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2024-06-26 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2024-06-27 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2024-07-18 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2024-07-18 | 8 RFCS P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 